# Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers

> **NCT07071649** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 40 (estimated)

## Conditions studied

- Alzheimer's Disease
- Biomarkers
- Non-invasive Diagnosis
- Phosphorylated Protein p-tau217

## Interventions

- **OTHER:** blood withdrawal

## Key facts

- **NCT ID:** NCT07071649
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-20
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07071649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07071649, "Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07071649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*